Heptares Therapeutics
Laura Cabarga is currently working as a Scientist at Sosei Heptares since June 2021. Prior to that, they worked as an RNA Extraction Technician at PerkinElmer, Inc. from November 2020 to March 2021.
Laura Cabarga received their Bachelor's degree in Biochemistry (clinical-oriented) from the University of Navarra, where they studied from 2014 to 2018. Following their undergraduate studies, they pursued a Master's degree in Neurociencia at the Universitat Autònoma de Barcelona from 2018 to 2019.
This person is not in any teams
Heptares Therapeutics
Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, StabilisedReceptors), overcoming a major limiting factor to the development of new drugs targeting this group.